XU CHERYL

Director Xu Cheryl purchased 5,000 shares at blended $2.88 on 2025-06-03; 5 prior SXTP buys all posted positive 90d returns (range +337.5% to +360.5%).

Xu Cheryl, a Director, executed two separate purchases totaling 5,000 shares for $14,410.00 on 2025-06-03, increasing her holdings by 46.2% from 10,816 to 15,816 shares. This filing is significant because her prior trade history at SXTP shows a striking pattern: all 5 prior buys at this ticker were well-timed, with 90-day returns ranging from +337.5% to +360.5%, and cross-ticker her track record shows a 100.00% 90-day win rate across 9 prior buys with an average 90-day return of +2034.8%. The company currently trades at $11.84, down 85.9% from its 52-week high of $84.24, though it has gained 21.3% in the last 30 days and 89.7% over 90 days. However, fundamentals show SXTP remains deeply unprofitable with a net income of $-1,876,549.00 despite revenue growth of +139.6% year-over-year, and the latest quarter showed only $163,552.00 in revenue against a $17.4M market cap. The insider's historical precision at this ticker contrasts sharply with the company's financial distress, making this purchase's timing and significance material for investors to monitor.

Director Xu Cheryl bought 13,000 shares (13.0K shares) for $21,400.00 ($21.4K) across 7 purchases; holdings rose 31.6%.

Director Xu Cheryl executed 7 separate purchases totaling 13,000 shares for $21,400.00 at prices ranging from $1.45 to $1.85 over three trading days (2024-12-12 through 2024-12-16), raising her holdings from 41,078 shares to 54,078 shares—a 31.6% increase in position size. Her prior two open-market purchases at 60 Degrees Pharmaceuticals delivered exceptional returns (30d +1358.4% and +18581.6%, 90d +1276.5% and +14607.2% respectively), demonstrating a strong track record of well-timed entry points at this ticker. The stock currently trades at $27.60, representing a 90.2% decline from its 52-week high of $283.20, yet the director's recent accumulation below $1.85 reflects accumulation during an extended drawdown; her purchases are occurring at prices substantially below current levels. This multi-leg purchase pattern mirrors her successful prior timing at SXTP and appears consistent with her historically effective entry discipline across the insider's trading history.

Director XU CHERYL buys 5,000 shares at $1.70 amid 91.2% drawdown from 52-week high; prior same-ticker buy gained +18581.6% in 90 days

XU CHERYL purchased 5,000 shares at $1.70, expanding her holdings by 13.9% at a price that is -91.2% from the 52-week high of $295.20. The current price of $26.00 reflects a -19.8% decline over 30 days and -61.6% over 90 days, placing this transaction in a severe downtrend. Her prior buy at this same ticker on 2024-01-31 achieved returns of +18581.6% over 90 days, suggesting her timing on SXTP historically has been exceptional. However, the company faces significant headwinds: it is unprofitable (net income of $-4,172,755.00 over the most recent full fiscal year) with minimal quarterly revenue of $124,972.00, though annual revenue growth stands at +13.6%. The stark contrast between her prior 90-day success at this ticker and the current severe valuation decline suggests this transaction warrants close examination of what has changed in the company's fundamentals or market positioning since her last well-timed entry.